Nachrichten zur Johnson & Johnson Aktie

Top Analyst Reports for Johnson & Johnson, Lam Research & Seagate

Johnson & Johnson beat Q2 estimates as growth in key drugs, MedTech and its pipeline helps offset Stelara headwinds. Read…

Johnson & Johnson Aktie: Pharma wächst, MedTech bremst

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson Controls (JCI) Stock Looks Stretched On Cash Flow Yet Reasonable On Earnings

After a strong five year run for Johnson Controls International, the stock no longer looks obviously cheap, with the Discounted…

OP-Roboter, Medikamente und Produktionsausbau! J&J hat abgeliefert und dürfte die 100 Mrd. USD knacken!

Hat Johnson & Johnson (i)(JNJ) im 2. Quartal 2026 abgeliefert? Für mich lautet die klare Antwort: Ja! Zwar reagierte die Wall…

ASML erhöht Gesamtjahresausblick - Apple mit starken iPhone-Verkaufszahlen - PayPal-Aktie im Aufwind

Wien (www.aktiencheck.de) - ASML (0%) konnte gestern die Umsatz- und Gewinnerwartungen für das zweite Quartal 2026 übertreffen, so die Analysten…

+++ Geschäftszahlen +++: Johnson & Johnson hebt Jahresziele an

Börsenrallye und ETF-Boom bescheren BlackRock Rekordergebnis +++ BASF hebt nach Gewinnsprung Jahresziele an Chipausrüster ASML steigert Umsatz +++ Der Newsblog.…

Is Johnson & Johnson a Buy After Its Latest Earnings Report?

Investors didnt seem to think so after the company published it.…

Johnson & Johnson Raises 2026 Outlook After Q2 Earnings Beat

Johnson & Johnson raises its 2026 outlook after Q2 earnings and revenues beat estimates, driven by Innovative Medicine strength and…

J&J falls despite a beat-and-raise quarter. Why were raising our price target anyways

Johnson & Johnsons quarter was imperfect, but enough is going right to validate our ownership of the stock.…

ROUNDUP: Johnson & Johnson profitiert von Krebsmitteln - hebt Jahresziele an

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson hat sich im zweiten Quartal trotz…

Johnson & Johnson’s Spravato sales growth supports psychedelic drug opportunity: Jefferies

Psychedelic drug developers including AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC), Compass Pathways (NASDAQ:CMPS) and Cybin Inc. (NYSE-A:CYBN, FRA:R7E) could...…

Johnson & Johnson Q2-Zahlen: Ausblick erneut leicht angehoben

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson profitiert weiterhin von Krebsmitteln - hebt Jahresziele an

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson hat sich im zweiten Quartal trotz…

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & ?Johnson also increased its full-year sales and ?profit ?forecast.…

Johnson & Johnson beats Q2 estimates, raises full-year 2026 guidance

Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter results and raised its full-year 2026 outlook, as strong pharmaceutical sales...…

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as strong growth from immunology drug…

Tech Futures Rise With Nasdaq At Key Level; Oil Pushes Above $80

ASML, Johnson & Johnson, PayPal lead early movers on news.…

Johnson & Johnson Aktie: Wachsende Zuversicht

Toronto (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von RBC Capital Markets:RBC Capital habe das Kursziel für die Aktie von Johnson &…

Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?

After hitting fresh all-time highs last week, investors are turning their attention to JNJs Q2 report, which is scheduled for…

Q2 Earnings Season Arrives: Can Results Match Upbeat Expectations?

The big banks dominate this weeks reporting docket, though several notable companies from other sectors will also report, including Netflix,…

Johnson Service backs outlook despite hospitality weakness

Johnson Service Group plc (LSE:JSG) said it remained on track to deliver its 2026 margin target despite continued weakness in…

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

Johnson & Johnson (JNJ) closed at $263.4 in the latest trading session, marking a -1.44% move from the prior day.…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Megatrend Folger: Johnson & Johnson erklimmt neues Allzeithoch

Zum Start in das verlängerte Feiertagswochenende in den USA rund um den 4. Juli zeigt sich an der Wall Street…

Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?

Johnson & Johnson doesnt need GLP-1 drugs to grow, and thats good news for long-term investors.…

[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Gauze…

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb trades at a deep discount, while Johnson & Johnson boasts higher margins and a broader reach. How…

Johnson & Johnson snaps six straight sessions of gains

…

Johnson & Johnson (JNJ) Surges 4.0%: Is This an Indication of Further Gains?

Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The…

Johnson & Johnson Aktie: Weiteres Potenzial vor den Zahlen

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Guggenheim Securities:Guggenheim-Analyst Vamil Divan habe das Kursziel für die Aktie von Johnson…

2 Blue Chip Industrial Stocks Id Buy Into This Weeks Weakness Without Hesitation

Investors looking for industrial stocks experiencing modest pullbacks might want to examine Canadian National Railway and Johnson Controls.…

J&J CEO Now Sees Line of Sight to Double-Digit Growth for His $100 Billion Company. Heres Why Investors Should Pay Attention.

Johnson & Johnson is a healthcare giant, but an opportunity to invest in the United States and a plethora of…

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts

Johnson & Johnson (JNJ) concluded the recent trading session at $244.88, signifying a +1.61% move from its prior days close.…

Ausbruch dank Novo Nordisk, UnitedHealth und Johnson & Johnson?

Der Chart sieht spannend aus. Dank der zuletzt soliden Performance von Aktien wie UnitedHealth, Novo Nordisk oder Johnson & Johnson…

Ausbruch dank Novo Nordisk, UnitedHealth und Johnson & Johnson?

Der Chart sieht spannend aus. Dank der zuletzt soliden Performance von Aktien wie UnitedHealth, Novo Nordisk oder Johnson & Johnson…

J&J CEO sends a clear message on the obesity drug boom

Johnson & Johnson (JNJ) just told Wall Street it will sit out the most lucrative drug race of the decade.…

Smart Money Is Fleeing Tech for Johnson & Johnson Ahead of the Next Market Storm

Bear markets are a part of investing life, but you can prepare for them ahead of time.…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Top Research Reports for Alphabet, Broadcom & Johnson & Johnson

Todays Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Broadcom Inc. (AVGO) and Johnson…

Johnson & Johnson auf Kurs zur 100 Mrd. USD-Umsatzmarke! Ich halte an meinen Aktien fest!

Nach der Abspaltung der Konsumgütersparte Kenvue 2023 hat sich Johnson & Johnson (i)(JNJ) erfolgreich als reines Innovationskraftwerk für Pharma und…

Johnson & Johnson to invest $1 billion in vision operations in Jacksonville

With $12 million in city incentives in hand, the company is building a distribution center in Northwest Jacksonville and upgrading…

Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts

Johnson & Johnson (JNJ) closed at $240.87 in the latest trading session, marking a +1.07% move from the prior day.…

Johnson & Johnson bets $1 billion on hard-to-treat cancer

Johnson & Johnson (JNJ) is one of the biggest names in health care, and lately, its stock has been living…

Johnson & Johnson to buy Firefly Bio for $1 billion

Johnson & Johnson said ?on Monday it will acquire ?biotech Firefly Bio for $1 billion in cash, as it ?looks…

Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock

Johnson & Johnson takes a licking, and the dividend keeps on ticking higher.…

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

In the latest trading session, Johnson & Johnson (JNJ) closed at $228.17, marking a +2.21% move from the previous day.…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

BEERSE, BELGIUM , June 03, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced nipocalimab met the…

Johnson & Johnson Hopes to Dethrone AbbVies Biggest Growth Driver. Heres Why Investors Shouldnt Panic

AbbVies shareholders can sleep easy.…